Global Pneumococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Pneumococcal Vaccine market size was valued at USD 7408.6 million in 2023 and is forecast to a readjusted size of USD 7972.1 million by 2030 with a CAGR of 1.1% during review period.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
The Global Info Research report includes an overview of the development of the Pneumococcal Vaccine industry chain, the market status of Child (PPSV 23, PCV 7/13), Adult (PPSV 23, PCV 7/13), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pneumococcal Vaccine.
Regionally, the report analyzes the Pneumococcal Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pneumococcal Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pneumococcal Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pneumococcal Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., PPSV 23, PCV 7/13).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pneumococcal Vaccine market.
Regional Analysis: The report involves examining the Pneumococcal Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pneumococcal Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pneumococcal Vaccine:
Company Analysis: Report covers individual Pneumococcal Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pneumococcal Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Child, Adult).
Technology Analysis: Report covers specific technologies relevant to Pneumococcal Vaccine. It assesses the current state, advancements, and potential future developments in Pneumococcal Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pneumococcal Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pneumococcal Vaccine market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Market segment by Type
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine from 2019 to 2024.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and end user, with sales market share and growth rate by type, end user, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pneumococcal Vaccine market forecast, by regions, type and end user, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccine.
Chapter 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.
North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
The Global Info Research report includes an overview of the development of the Pneumococcal Vaccine industry chain, the market status of Child (PPSV 23, PCV 7/13), Adult (PPSV 23, PCV 7/13), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pneumococcal Vaccine.
Regionally, the report analyzes the Pneumococcal Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pneumococcal Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pneumococcal Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pneumococcal Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., PPSV 23, PCV 7/13).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pneumococcal Vaccine market.
Regional Analysis: The report involves examining the Pneumococcal Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pneumococcal Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pneumococcal Vaccine:
Company Analysis: Report covers individual Pneumococcal Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pneumococcal Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Child, Adult).
Technology Analysis: Report covers specific technologies relevant to Pneumococcal Vaccine. It assesses the current state, advancements, and potential future developments in Pneumococcal Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pneumococcal Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pneumococcal Vaccine market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Market segment by Type
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Pneumococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine, with price, sales, revenue and global market share of Pneumococcal Vaccine from 2019 to 2024.
Chapter 3, the Pneumococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and end user, with sales market share and growth rate by type, end user, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pneumococcal Vaccine market forecast, by regions, type and end user, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccine.
Chapter 14 and 15, to describe Pneumococcal Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pneumococcal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pneumococcal Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 PPSV
1.3.3 PCV 7/13
1.3.4 PCV
1.4 Market Analysis by End User
1.4.1 Overview: Global Pneumococcal Vaccine Consumption Value by End User: 2019 Versus 2023 Versus 2030
1.4.2 Child
1.4.3 Adult
1.5 Global Pneumococcal Vaccine Market Size & Forecast
1.5.1 Global Pneumococcal Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pneumococcal Vaccine Sales Quantity (2019-2030)
1.5.3 Global Pneumococcal Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Pneumococcal Vaccine Product and Services
2.1.4 Pfizer Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pneumococcal Vaccine Product and Services
2.2.4 GSK Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 MSD
2.3.1 MSD Details
2.3.2 MSD Major Business
2.3.3 MSD Pneumococcal Vaccine Product and Services
2.3.4 MSD Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 MSD Recent Developments/Updates
2.4 Sanofipasteur
2.4.1 Sanofipasteur Details
2.4.2 Sanofipasteur Major Business
2.4.3 Sanofipasteur Pneumococcal Vaccine Product and Services
2.4.4 Sanofipasteur Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofipasteur Recent Developments/Updates
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business
2.5.3 CDIBP Pneumococcal Vaccine Product and Services
2.5.4 CDIBP Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CDIBP Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PNEUMOCOCCAL VACCINE BY MANUFACTURER
3.1 Global Pneumococcal Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pneumococcal Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Pneumococcal Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pneumococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2023
3.5 Pneumococcal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pneumococcal Vaccine Market: Region Footprint
3.5.2 Pneumococcal Vaccine Market: Company Product Type Footprint
3.5.3 Pneumococcal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pneumococcal Vaccine Market Size by Region
4.1.1 Global Pneumococcal Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Pneumococcal Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Pneumococcal Vaccine Average Price by Region (2019-2030)
4.2 North America Pneumococcal Vaccine Consumption Value (2019-2030)
4.3 Europe Pneumococcal Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Pneumococcal Vaccine Consumption Value (2019-2030)
4.5 South America Pneumococcal Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Pneumococcal Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Pneumococcal Vaccine Consumption Value by Type (2019-2030)
5.3 Global Pneumococcal Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY END USER
6.1 Global Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
6.2 Global Pneumococcal Vaccine Consumption Value by End User (2019-2030)
6.3 Global Pneumococcal Vaccine Average Price by End User (2019-2030)
7 NORTH AMERICA
7.1 North America Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
7.3 North America Pneumococcal Vaccine Market Size by Country
7.3.1 North America Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Pneumococcal Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
8.3 Europe Pneumococcal Vaccine Market Size by Country
8.3.1 Europe Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Pneumococcal Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
9.3 Asia-Pacific Pneumococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
10.3 South America Pneumococcal Vaccine Market Size by Country
10.3.1 South America Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Pneumococcal Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
11.3 Middle East & Africa Pneumococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pneumococcal Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Pneumococcal Vaccine Market Drivers
12.2 Pneumococcal Vaccine Market Restraints
12.3 Pneumococcal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pneumococcal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pneumococcal Vaccine
13.3 Pneumococcal Vaccine Production Process
13.4 Pneumococcal Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pneumococcal Vaccine Typical Distributors
14.3 Pneumococcal Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Pneumococcal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pneumococcal Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 PPSV
1.3.3 PCV 7/13
1.3.4 PCV
1.4 Market Analysis by End User
1.4.1 Overview: Global Pneumococcal Vaccine Consumption Value by End User: 2019 Versus 2023 Versus 2030
1.4.2 Child
1.4.3 Adult
1.5 Global Pneumococcal Vaccine Market Size & Forecast
1.5.1 Global Pneumococcal Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pneumococcal Vaccine Sales Quantity (2019-2030)
1.5.3 Global Pneumococcal Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Pneumococcal Vaccine Product and Services
2.1.4 Pfizer Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Pneumococcal Vaccine Product and Services
2.2.4 GSK Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 MSD
2.3.1 MSD Details
2.3.2 MSD Major Business
2.3.3 MSD Pneumococcal Vaccine Product and Services
2.3.4 MSD Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 MSD Recent Developments/Updates
2.4 Sanofipasteur
2.4.1 Sanofipasteur Details
2.4.2 Sanofipasteur Major Business
2.4.3 Sanofipasteur Pneumococcal Vaccine Product and Services
2.4.4 Sanofipasteur Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sanofipasteur Recent Developments/Updates
2.5 CDIBP
2.5.1 CDIBP Details
2.5.2 CDIBP Major Business
2.5.3 CDIBP Pneumococcal Vaccine Product and Services
2.5.4 CDIBP Pneumococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CDIBP Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PNEUMOCOCCAL VACCINE BY MANUFACTURER
3.1 Global Pneumococcal Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pneumococcal Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Pneumococcal Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pneumococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Pneumococcal Vaccine Manufacturer Market Share in 2023
3.5 Pneumococcal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pneumococcal Vaccine Market: Region Footprint
3.5.2 Pneumococcal Vaccine Market: Company Product Type Footprint
3.5.3 Pneumococcal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pneumococcal Vaccine Market Size by Region
4.1.1 Global Pneumococcal Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Pneumococcal Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Pneumococcal Vaccine Average Price by Region (2019-2030)
4.2 North America Pneumococcal Vaccine Consumption Value (2019-2030)
4.3 Europe Pneumococcal Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Pneumococcal Vaccine Consumption Value (2019-2030)
4.5 South America Pneumococcal Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Pneumococcal Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Pneumococcal Vaccine Consumption Value by Type (2019-2030)
5.3 Global Pneumococcal Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY END USER
6.1 Global Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
6.2 Global Pneumococcal Vaccine Consumption Value by End User (2019-2030)
6.3 Global Pneumococcal Vaccine Average Price by End User (2019-2030)
7 NORTH AMERICA
7.1 North America Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
7.3 North America Pneumococcal Vaccine Market Size by Country
7.3.1 North America Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Pneumococcal Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
8.3 Europe Pneumococcal Vaccine Market Size by Country
8.3.1 Europe Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Pneumococcal Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
9.3 Asia-Pacific Pneumococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
10.3 South America Pneumococcal Vaccine Market Size by Country
10.3.1 South America Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Pneumococcal Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2019-2030)
11.3 Middle East & Africa Pneumococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pneumococcal Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Pneumococcal Vaccine Market Drivers
12.2 Pneumococcal Vaccine Market Restraints
12.3 Pneumococcal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pneumococcal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pneumococcal Vaccine
13.3 Pneumococcal Vaccine Production Process
13.4 Pneumococcal Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pneumococcal Vaccine Typical Distributors
14.3 Pneumococcal Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pneumococcal Vaccine Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Pneumococcal Vaccine Product and Services
Table 6. Pfizer Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Pneumococcal Vaccine Product and Services
Table 11. GSK Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. MSD Basic Information, Manufacturing Base and Competitors
Table 14. MSD Major Business
Table 15. MSD Pneumococcal Vaccine Product and Services
Table 16. MSD Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. MSD Recent Developments/Updates
Table 18. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 19. Sanofipasteur Major Business
Table 20. Sanofipasteur Pneumococcal Vaccine Product and Services
Table 21. Sanofipasteur Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Sanofipasteur Recent Developments/Updates
Table 23. CDIBP Basic Information, Manufacturing Base and Competitors
Table 24. CDIBP Major Business
Table 25. CDIBP Pneumococcal Vaccine Product and Services
Table 26. CDIBP Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. CDIBP Recent Developments/Updates
Table 28. Global Pneumococcal Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 29. Global Pneumococcal Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Pneumococcal Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 31. Market Position of Manufacturers in Pneumococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Pneumococcal Vaccine Production Site of Key Manufacturer
Table 33. Pneumococcal Vaccine Market: Company Product Type Footprint
Table 34. Pneumococcal Vaccine Market: Company Product Application Footprint
Table 35. Pneumococcal Vaccine New Market Entrants and Barriers to Market Entry
Table 36. Pneumococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 38. Global Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 39. Global Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Pneumococcal Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 42. Global Pneumococcal Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 43. Global Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 44. Global Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 45. Global Pneumococcal Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Pneumococcal Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Pneumococcal Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 48. Global Pneumococcal Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 49. Global Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 50. Global Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 51. Global Pneumococcal Vaccine Consumption Value by End User (2019-2024) & (USD Million)
Table 52. Global Pneumococcal Vaccine Consumption Value by End User (2025-2030) & (USD Million)
Table 53. Global Pneumococcal Vaccine Average Price by End User (2019-2024) & (USD/Dose)
Table 54. Global Pneumococcal Vaccine Average Price by End User (2025-2030) & (USD/Dose)
Table 55. North America Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 56. North America Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 57. North America Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 58. North America Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 59. North America Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 60. North America Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 61. North America Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 64. Europe Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 65. Europe Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 66. Europe Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 67. Europe Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 68. Europe Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 69. Europe Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 72. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 73. Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 74. Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 75. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 76. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 77. Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 80. South America Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 81. South America Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 82. South America Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 83. South America Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 84. South America Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 85. South America Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 88. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 89. Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 90. Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 91. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 92. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 93. Middle East & Africa Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Pneumococcal Vaccine Raw Material
Table 96. Key Manufacturers of Pneumococcal Vaccine Raw Materials
Table 97. Pneumococcal Vaccine Typical Distributors
Table 98. Pneumococcal Vaccine Typical Customers
Table 1. Global Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pneumococcal Vaccine Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Pneumococcal Vaccine Product and Services
Table 6. Pfizer Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Pneumococcal Vaccine Product and Services
Table 11. GSK Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. MSD Basic Information, Manufacturing Base and Competitors
Table 14. MSD Major Business
Table 15. MSD Pneumococcal Vaccine Product and Services
Table 16. MSD Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. MSD Recent Developments/Updates
Table 18. Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table 19. Sanofipasteur Major Business
Table 20. Sanofipasteur Pneumococcal Vaccine Product and Services
Table 21. Sanofipasteur Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Sanofipasteur Recent Developments/Updates
Table 23. CDIBP Basic Information, Manufacturing Base and Competitors
Table 24. CDIBP Major Business
Table 25. CDIBP Pneumococcal Vaccine Product and Services
Table 26. CDIBP Pneumococcal Vaccine Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. CDIBP Recent Developments/Updates
Table 28. Global Pneumococcal Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 29. Global Pneumococcal Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Pneumococcal Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 31. Market Position of Manufacturers in Pneumococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Pneumococcal Vaccine Production Site of Key Manufacturer
Table 33. Pneumococcal Vaccine Market: Company Product Type Footprint
Table 34. Pneumococcal Vaccine Market: Company Product Application Footprint
Table 35. Pneumococcal Vaccine New Market Entrants and Barriers to Market Entry
Table 36. Pneumococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 38. Global Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 39. Global Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Pneumococcal Vaccine Average Price by Region (2019-2024) & (USD/Dose)
Table 42. Global Pneumococcal Vaccine Average Price by Region (2025-2030) & (USD/Dose)
Table 43. Global Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 44. Global Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 45. Global Pneumococcal Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Pneumococcal Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Pneumococcal Vaccine Average Price by Type (2019-2024) & (USD/Dose)
Table 48. Global Pneumococcal Vaccine Average Price by Type (2025-2030) & (USD/Dose)
Table 49. Global Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 50. Global Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 51. Global Pneumococcal Vaccine Consumption Value by End User (2019-2024) & (USD Million)
Table 52. Global Pneumococcal Vaccine Consumption Value by End User (2025-2030) & (USD Million)
Table 53. Global Pneumococcal Vaccine Average Price by End User (2019-2024) & (USD/Dose)
Table 54. Global Pneumococcal Vaccine Average Price by End User (2025-2030) & (USD/Dose)
Table 55. North America Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 56. North America Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 57. North America Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 58. North America Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 59. North America Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 60. North America Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 61. North America Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 64. Europe Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 65. Europe Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 66. Europe Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 67. Europe Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 68. Europe Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 69. Europe Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 72. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 73. Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 74. Asia-Pacific Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 75. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 76. Asia-Pacific Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 77. Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 80. South America Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 81. South America Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 82. South America Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 83. South America Pneumococcal Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
Table 84. South America Pneumococcal Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
Table 85. South America Pneumococcal Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Pneumococcal Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
Table 88. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
Table 89. Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2019-2024) & (K Doses)
Table 90. Middle East & Africa Pneumococcal Vaccine Sales Quantity by End User (2025-2030) & (K Doses)
Table 91. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
Table 92. Middle East & Africa Pneumococcal Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
Table 93. Middle East & Africa Pneumococcal Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Pneumococcal Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Pneumococcal Vaccine Raw Material
Table 96. Key Manufacturers of Pneumococcal Vaccine Raw Materials
Table 97. Pneumococcal Vaccine Typical Distributors
Table 98. Pneumococcal Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Pneumococcal Vaccine Picture
Figure 2. Global Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pneumococcal Vaccine Consumption Value Market Share by Type in 2023
Figure 4. PPSV 23 Examples
Figure 5. PCV 7/13 Examples
Figure 6. PCV 10 Examples
Figure 7. Global Pneumococcal Vaccine Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Pneumococcal Vaccine Consumption Value Market Share by End User in 2023
Figure 9. Child Examples
Figure 10. Adult Examples
Figure 11. Global Pneumococcal Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Pneumococcal Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Pneumococcal Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 14. Global Pneumococcal Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 15. Global Pneumococcal Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Pneumococcal Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Pneumococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Pneumococcal Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Pneumococcal Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 30. Global Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 31. Global Pneumococcal Vaccine Consumption Value Market Share by End User (2019-2030)
Figure 32. Global Pneumococcal Vaccine Average Price by End User (2019-2030) & (USD/Dose)
Figure 33. North America Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 35. North America Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 42. Europe Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 51. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 61. South America Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 67. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Pneumococcal Vaccine Market Drivers
Figure 74. Pneumococcal Vaccine Market Restraints
Figure 75. Pneumococcal Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2023
Figure 78. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 79. Pneumococcal Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Pneumococcal Vaccine Picture
Figure 2. Global Pneumococcal Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pneumococcal Vaccine Consumption Value Market Share by Type in 2023
Figure 4. PPSV 23 Examples
Figure 5. PCV 7/13 Examples
Figure 6. PCV 10 Examples
Figure 7. Global Pneumococcal Vaccine Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Pneumococcal Vaccine Consumption Value Market Share by End User in 2023
Figure 9. Child Examples
Figure 10. Adult Examples
Figure 11. Global Pneumococcal Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Pneumococcal Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Pneumococcal Vaccine Sales Quantity (2019-2030) & (K Doses)
Figure 14. Global Pneumococcal Vaccine Average Price (2019-2030) & (USD/Dose)
Figure 15. Global Pneumococcal Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Pneumococcal Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Pneumococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Pneumococcal Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Pneumococcal Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Pneumococcal Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Pneumococcal Vaccine Average Price by Type (2019-2030) & (USD/Dose)
Figure 30. Global Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 31. Global Pneumococcal Vaccine Consumption Value Market Share by End User (2019-2030)
Figure 32. Global Pneumococcal Vaccine Average Price by End User (2019-2030) & (USD/Dose)
Figure 33. North America Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 35. North America Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 42. Europe Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 51. Asia-Pacific Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 53. China Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 61. South America Pneumococcal Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Pneumococcal Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by End User (2019-2030)
Figure 67. Middle East & Africa Pneumococcal Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Pneumococcal Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Pneumococcal Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Pneumococcal Vaccine Market Drivers
Figure 74. Pneumococcal Vaccine Market Restraints
Figure 75. Pneumococcal Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine in 2023
Figure 78. Manufacturing Process Analysis of Pneumococcal Vaccine
Figure 79. Pneumococcal Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
